A+ A A-

What's New

New to Portal

  • New examples now available.
    09-02-2015

  • Peruse MicrobeLibrary's updated ASM curriculum and biosafety teaching guidelines. 
    08-31-2015

  • View presentation slides from the asm2015 Session- "Bench Bacteriology:  Practical Guidance You Can Actually Use!".
    08-12-2015

  • A popular feature of the Journal of Clinical Microbiology. A new quiz is now posted.
    08-10-2015

  • ASM's August Hot Topic, "Non-Tuberculous Mycobacterium sp.: What’s New in 2015?" was presented by...
    08-03-2015

ASM Updates

News Digest

Public Policy

Upcoming Events

Career Connections


Featured Content

  • NARMS Now: An interactive tool from the CDC containing antibiotic resistance data

    NARMS Now: An interactive tool from the CDC containing antibiotic resistance data

    Welcome to NARMS Now: Human Data, an interactive tool from CDC that contains antibiotic resistance data from bacteria isolated from humans as part of the National Antimicrobial Resistance Monitoring System (NARMS). NARMS Now: Human Data makes it easier and quicker to find out how antibiotic resistance has changed over the past 20 years for four bacteria transmitted commonly through food.

  • ICAAC/ICC 2015

    ICAAC/ICC 2015

    Register now for ICAAC/ICC 2015, and you could win a free copy of the recently published Manual of Clinical Microbiology, 11th Edition – a $299 value! One winner will be selected each month through random drawing.

  • Cytopathology and More—Primary HPV screening, Pap-HPV cotesting: interim guidance and a retrospective study

    Cytopathology and More—Primary HPV screening, Pap-HPV cotesting: interim guidance and a retrospective study

    August 2015—The Food and Drug Administration in 2001 approved the use of high-risk HPV testing to triage ASCUS Pap test results (reflex testing). Two years later the FDA expanded the indications for hrHPV testing to include its use as an adjunct to cytology in women over age 30 (cotesting). The rationale for age 30 as a cotesting cutoff point was that hrHPV is common in sexually active young women and most infections are transient and clear without medical intervention. Cotesting has since been widely adopted and multiple FDA-approved testing platforms are being used in the United States...

  • Antimicrobial Agents and Chemotherapy® (AAC) has launched a new section

    Antimicrobial Agents and Chemotherapy® (AAC) has launched a new section

    In response to the rise in antibiotic resistance, Antimicrobial Agents and Chemotherapy® (AAC) has launched a new section, Challenging Clinical Cases in Antimicrobial Resistance (CCCAR). CCCARs are brief articles designed to familiarize and provide guidance to the reader on the clinical approach to the treatment of real, challenging cases involving multidrug-resistant organisms.


topics 10072014 qa 10072014 cumitechs 10072014 

Advertisement

American Society For Microbiology © 2015 | Privacy Policy | Terms of Use